ANAVEX LIFE SCIENCES CORP. (AVXL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0327973006
ANAVEX LIFE SCIENCES CORP. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -51.41 m USD |
| EBIT | -46.38 m USD |
| Net income | -46.38 m USD |
| Diluted EPS – continuing operations | -0.54 USD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ANAVEX LIFE SCIENCES CORP.
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine), has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-concept study in Parkinson's disease dementia; and a Phase 2 and a Phase 3 study in adult patients and one Phase 2/3 study in pediatric patients with Rett syndrome. Its ANAVEX 2-73 is an orally available drug candidate designed to restore cellular homeostasis by targeting SIGMAR1 and muscarinic receptors. The ANAVEX 2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The company's ANAVEX 3-71, which targets SIGMAR1 and M1 muscarinic receptors, is a clinical stage drug candidate demonstrating disease-modifying activity against Alzheimer's disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid, and tau pathologies. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.
More stocks
- ATW Technology Inc (8097.TWO)
- Global AI, Inc. (GLAI)
- Dekuple (DKUPL.PA)
- M.I.TECH Co.Ltd (179290.KQ)
- Cincon Electronics Co Ltd (3332.TWO)
- WW Holding Inc (8442.TW)
- Bunker Hill Mining Corp. (BHLL)
- CAPITAL PROPERTIES INC /RI/ (CPTP)
- JOINT Corp (JYNT)
- Alan Allman Associates SA (AAA.PA)
- eWork Group AB (EWRK.ST)
- DeFi Development Corp. (DFDV)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.